Publication:
Mesalazine induced interstitial pneumonitis in the COVID era.

Simple item page
dc.contributor.authorAparicio Serrano, Ana
dc.contributor.authorGallego Jimenez, Elma
dc.contributor.authorCastro Rodriguez, Javier
dc.contributor.authorSoto Escribano, Pilar
dc.contributor.authorIglesias Flores, Eva
dc.contributor.authorMarin Pedrosa, Sandra
dc.contributor.authorBenitez, Jose Manuel
dc.date.accessioned2023-05-03T14:30:23Z
dc.date.available2023-05-03T14:30:23Z
dc.date.issued2022
dc.description.abstractMesalazine is the most widely used aminosalicylate for induction and maintenance of remission in patients with mild-to-moderate ulcerative colitis (UC). Drug-induced hypersensitivity pneumonitis is considered very rare (< 1/10 000 patients).
dc.identifier.citationSerrano AA, Jiménez EG, Rodríguez JC, Escribano PS, Flores EI, Pedrosa SM, et al. Mesalazine induced interstitial pneumonitis in the COVID era. Revista Española de Enfermedades Digestivas [Internet]. 1 de enero de 2022
dc.identifier.doi10.17235/reed.2022.8635/2021
dc.identifier.issn1130-0108
dc.identifier.pmid35199533
dc.identifier.unpaywallURLhttps://online.reed.es/DOI/PDF/ArticuloDOI_8635.pdf
dc.identifier.urihttp://hdl.handle.net/10668/21728
dc.issue.number7
dc.journal.titleRevista espanola de enfermedades digestivas
dc.journal.titleabbreviationRev Esp Enferm Dig
dc.language.isoen
dc.organizationHospital Universitario Reina Sofía
dc.organizationInstituto Maimónides de Investigación Biomédica de Córdoba-IMIBIC
dc.page.number429-430
dc.provenanceRealizada la curación de contenido 14/08/2024
dc.publisherSociedad Espanola de Patologia Digestiva
dc.pubmedtypeLetter
dc.relation.publisherversionhttps://www.reed.es/ArticuloFicha.aspx?id=6660&hst=0&idR=110&tp=1
dc.rights.accessRightsopen access
dc.subjectMesalazine
dc.subjectLung injury
dc.subjectUlcerative colitis
dc.subject.decsAlveolitis alérgica extrínseca
dc.subject.decsColitis ulcerosa
dc.subject.decsMantenimiento
dc.subject.decsMesalamina
dc.subject.decsPacientes
dc.subject.decsPreparaciones farmacéuticas
dc.subject.meshAnti-inflammatory agents, non-steroidal
dc.subject.meshCOVID-19
dc.subject.meshColitis, ulcerative
dc.subject.meshHumans
dc.subject.meshLung diseases, interstitial
dc.subject.meshMesalamine
dc.titleMesalazine induced interstitial pneumonitis in the COVID era.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number114
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
RISalud_Accesorestringido.pdf
Size:
93.39 KB
Format:
Adobe Portable Document Format
Download

Collections

Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)
SAS - Hospital Universitario Reina Sofía

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía